Andrew A. Dahl, MD, is a board-certified ophthalmologist. Dr. Dahl's educational background includes a BA with Honors and Distinction from Wesleyan University, Middletown, CT, and an MD from Cornell University, where he was selected for Alpha Omega Alpha, the national medical honor society. He had an internal medical internship at the New York Hospital/Cornell Medical Center.
Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.
"Primary Angle Closure (Preferred Practice Pattern)." American Academy of Ophthalmology. 2005.
"Primary Open-Angle Glaucoma, Limited Revision (Preferred Practice Pattern)." American Academy of Ophthalmology. 2005.
"Primary Open-Angle Glaucoma Suspect (Preferred Practice Pattern)." American Academy of Ophthalmology. Oct. 2010.
Gordon, M. O., et al. "The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma." Archives of Ophthalmology 120.6 (2002): 714-720.
Lichter, P. R., et al. "Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery." Ophthalmology 108.11 (2001): 1943-1953.
Previous contributing editors: Richard W Allinson, MD, Associate Professor, Division of Ophthalmology, Texas A&M University Health Science Center, Associate Professor, Department of Surgery, Scott and White Clinic; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Robert H Graham, MD, Ophthalmologist, Robert H Graham, MD, PC; Affiliated With Department of Ophthalmology, Mayo Clinic, Scottsdale, Arizona and Carl T Hayden VA Medical Center, Phoenix, Arizona.